Reducing Opioid Overdoses – You Can Improve Access to Naloxone - Ordre des pharmaciens du Québec (OPQ)
Opioid-related harms are not solely caused by illicit opioids but are also commonly due to prescription opioids dispensed every day in pharmacy practice.
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1 CEU. CCCEP File Number: 1066-2019-2740-I-P
Michael Boivin, B. Pharm., CDE, CTE, CTH
Carole Dion, BSc. Pharm, R.Ph
Mark Barnes, BSc Chem, BSc Pharm, RPh
After successful completion of the program, the participant will be able to:
- Review risk factors which increase the risk of overdose from prescription opioids;
- Approach patients at risk of opioid-related harm to discuss the benefits of naloxone rescue therapy;
- Examine the differences between injectable and nasal naloxone therapy options;
- Discuss the role and responsibilities of the pharmacist to reduce opioid-related overdoses due to prescription opioids.